Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.950
-0.010 (-0.51%)
Nov 13, 2025, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,361
Profits / Employee
-$806,660
Market Cap
133.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 134 | 12 | 9.84% |
| Dec 31, 2023 | 122 | -62 | -33.70% |
| Dec 31, 2022 | 184 | -133 | -41.96% |
| Dec 31, 2021 | 317 | 55 | 20.99% |
| Dec 31, 2020 | 262 | 72 | 37.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INO News
- 1 day ago - Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress - Seeking Alpha
- 2 days ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 3 days ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 3 days ago - INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 10 days ago - INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PRNewsWire
- 13 days ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 17 days ago - INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 - PRNewsWire